Skip to main content

Table 3 Univariate analysis of preoperative risk factors for permanent stoma in a group of ileostomy patients (group A)

From: Assessment of the risk of permanent stoma after low anterior resection in rectal cancer patients

   

Permanent stoma

  
  

Total (N = 101)

Yes (N = 38)

No (N = 63)

Test

p value

Sex

Female

33.7% (N = 34)

21.1% (N = 8)

41.3% (N = 26)

Chi-square

0.0621

Male

66.3% (N = 67)

78.9% (N = 30)

58.7% (N = 37)

Age

N

101

38

63

Mann-Whitney U

0.5722

Mean (SD)

61.98 (10.6)

61.61 (10.39)

62.21 (10.81)

Median (IQR)

61 (55–71)

60 (55–71.75)

62 (56.5–69)

Range

29–83

40–82

29–83

Age ≥ 65

Yes

41.6% (N = 42)

36.8% (N = 14)

44.4% (N = 28)

Chi-square

0.5874

No

58.4% (N = 59)

63.2% (N = 24)

55.6% (N = 35)

BMI

N

101

38

63

Mann-Whitney U

0.4241

Mean (SD)

26.86 (4.41)

26.61 (4.75)

27.02 (4.23)

Median (IQR)

26 (23.8–29.7)

25.75 (23.1–29.38)

26.1 (24.2–29.75)

Range

18.4–42.6

18.4–38.7

19.4–42.6

BMI ≥ 30

Yes

23.8% (N = 24)

23.7% (N = 9)

23.8% (N = 15)

Chi-square

1

No

76.2% (N = 77)

76.3% (N = 29)

76.2% (N = 48)

BSA

N

101

38

63

Mann-Whitney U

0.3732

Mean (SD)

1.87 (0.22)

1.9 (0.24)

1.86 (0.21)

Median (IQR)

1.88 (1.71–2.04)

1.9 (1.7–2.08)

1.85 (1.72–1.99)

Range

1.32 – 2.42

1.4 – 2.42

1.32 – 2.38

CAD

Yes

6.9% (N = 7)

10.5% (N = 4)

4.8% (N = 3)

Fisher

0.4206

No

93.1% (N = 94)

89.5% (N = 34)

95.2% (N = 60)

HA

Yes

37.6% (N = 38)

39.5% (N = 15)

36.5% (N = 23)

Chi-square

0.9314

No

62.4% (N = 63)

60.5% (N = 23)

63.5% (N = 40)

DM

Yes

12.9% (N = 13)

15.8% (N = 6)

11.1% (N = 7)

Chi-square

0.7088

No

87.1% (N = 88)

84.2% (N = 32)

88.9% (N = 56)

CCI

0

69.3% (N = 70)

52.6%(N = 20)

79.4% (N = 50)

Fisher

< 0.001

1–5

23.8% (N = 24)

28.9% (N = 11)

20.6% (N = 13)

> 5

6.9% (N = 7)

18.4% (N = 7)

0% (N = 0)

Clinical stage

IV

6.9% (N = 7)

18.4% (N = 7)

0% (N = 0)

Fisher

< 0.001

I–III

93.1% (N = 94)

81.6%(N = 31)

100% (N = 63)

Time RT-OPER

No RT

20.8% (N = 21)

18.4% (N = 7)

22.2% (N = 14)

Chi-square

0.374

≥ 6 weeks

50.5% (N = 51)

44.7% (N = 17)

54% (N = 34)

< 6 weeks

28.7% (N = 29)

36.8% (N = 14)

23.8% (N = 15)

FIBR

N

100

38

63

Mann-Whitney U

0.0073

Mean (SD)

364.4 (88.05)

400.08 (116.1)

342.53 (55.93)

Median (IQR)

351 (301.75–419.25)

410.5 (301.5–467.75)

341 (303.75–375)

Range

212–721

212–721

242–491

NLR

N

101

38

63

Mann-Whitney U

0.2119

Mean (SD)

3.88 (2.06)

4.33 (2.45)

3.61 (1.75)

Median (IQR)

3.3 (2.5–5.1)

3.5 (2.6–5.8)

3.1 (2.45–4.45)

Range

1–12.2

1–12.2

1 – 9.9

PLR

N

101

38

63

Mann-Whitney U

0.8499

Mean (SD)

262.2 (141.13)

269.6 (174.16)

257.73 (118.2)

Median (IQR)

232.9 (161.9–337.9)

244.45 (143.93–351.9)

232.9 (164.25–335.15)

Range

49.3–918.8

49.3–918.8

74.2–509.5

PNI

N

101

38

63

Mann-Whitney U

0.1567

Mean (SD)

41.41 (4.14)

40.41 (4.74)

42.01 (3.63)

Median (IQR)

41.7 (39.8–43.7)

41.7 (38.52–43.12)

41.7 (39.9–44.15)

Range

18.4–51

18.4–47.9

28.3–51

  1. SD standard deviation, IQR interquartile range, BMI body mass index, BSA body surface area, CAD coronary artery disease, DM diabetes mellitus, HA arterial hypertension, CCI Charlson comorbidity index, Time RT-OPER time from completion of radiotherapy to operation, FIBR preoperative plasma fibrinogen concentration [mg/dl], NLR neutrophil-to-lymphocyte ratio, PLT platelet-to-lymphocyte ratio, PNI Prognostic Nutritional Index